Cigna Group Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
7.5%projected annual EPS growth
Analyst Coverage
24analysts covering
FY Revenue (est.)
$286.6Bnext fiscal year
FY EPS (est.)
$30.51next fiscal year
Monitoring Framework
Key Performance Indicators
Cigna Healthcare Medical Care Ratio (MCR) Quarterly79.8%Target: Low-to-mid 80% range for full year
Total Customer Relationships Quarterly185.5MTarget: Sustained growth across pharmacy and medical segments
Evernorth Health Services Adjusted Revenues Quarterly58.4BTarget: High-single-digit to double-digit growth driven by specialty pharmacy
Watch Items
- PBM Regulatory Reform and Rebate DelinkingTrigger: Enactment of federal laws mandating 100% rebate pass-through or complete delinking in commercial plansAction: Accelerate transition of remaining client base to the Signature rebate-free pharmacy model to protect Evernorth margins.
- Leadership Transition ExecutionTrigger: Brian Evanko succeeding David Cordani as CEO on July 1, 2026Action: Monitor operational continuity, strategic alignment, and execution of AI-enabled care management programs.
- Medical Cost Inflation and Underwriting DisciplineTrigger: MCR exceeding full-year guidance due to elevated utilization or inadequate pricingAction: Re-price risk products, adjust underwriting guidelines, and expand AI-driven care management to curb medical expenses.
Research as of 2 Sep 2026